Duloxetine a new serotonin and noradrenaline reuptake inhibitor for the treatment of both major depressive disorder and female stress urinary incontinence: the implication of more than one indication for a new therapeutic agent

Author： Voss Simon   Gandhi Paul   Porkess Sheuli   Viktrup Lars  

Publisher： Radcliffe Press

ISSN： 1476-4709

Source： Primary Care Mental Health, Vol.3, Iss.2, 2005-06, pp. : 83-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implication of Circadian Rhythms and Melatonin in Major Depressive Disorder: The Evidence Base for New Antidepressant Treatment

By  

Current Psychiatry Reviews, Vol. 10, Iss. 3, 2014-08 ,pp. : 223-234

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Pain on Outcomes in a Trial of Duloxetine Treatment of Major Depressive Disorder

By Arnold Lesley  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 20, Iss. 4, 2008-11 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

By Vigo Daniel   Baldessarini Ross  

Harvard Review of Psychiatry, Vol. 17, Iss. 4, 2009-08 ,pp. : 231-241

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan   Despiegel Nicolas   Heldbo Reines Elin  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite

The bipolar diathesis of treatment-resistant major depressive disorder

By Woo Young Sup   Chae Jeong-ho   Jun Tae-youn   Kim Kwang-soo   Bahk Won-myong  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 2, 2008-06 ,pp. : 142-146

Ashgate Publishing Ltd

Access to resources Recommend Favorite